Cargando…
Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1
Wolfram syndrome 1 is a very rare monogenic disease resulting in a complex of disorders including diabetes mellitus. Up to now, insulin has been used to treat these patients. Some of the monogenic forms of diabetes respond preferentially to sulphonylurea preparations. The aim of the current study wa...
Autores principales: | Sedman, Tuuli, Rünkorg, Kertu, Krass, Maarja, Luuk, Hendrik, Plaas, Mario, Vasar, Eero, Volke, Vallo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812441/ https://www.ncbi.nlm.nih.gov/pubmed/27069934 http://dx.doi.org/10.1155/2016/9239530 |
Ejemplares similares
-
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
por: Heinla, Keiu, et al.
Publicado: (2023) -
Wfs1-deficient mice display altered function of serotonergic system and increased behavioral response to antidepressants
por: Visnapuu, Tanel, et al.
Publicado: (2013) -
Preventive treatment with liraglutide protects against development of glucose intolerance in a rat model of Wolfram syndrome
por: Toots, Maarja, et al.
Publicado: (2018) -
Wfs1- deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration
por: Plaas, Mario, et al.
Publicado: (2017) -
Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
por: Volke, Vallo, et al.
Publicado: (2022)